Public disclosure of inside information according to article 17 MAR

Biofrontera AG: DISCLOSURE OF INSIDE INFORMATION PURSUANT TO ARTICLE 17 MAR

Leverkusen (pta048/14.04.2025/21:35 UTC+2)

"

Leverkusen (14.04.2025/20:00 h) –

By the end of 2024, Biofrontera AG had largely met the forecast published on November 28, 2024. The company generated revenues of kEUR 21,666, had liquidity of kEUR 3,124, and reported an EBIT of kEUR -5,473. Only the EBITDA of kEUR -4,635 (the forecast was between kEUR -4,500 and kEUR -2,500) was slightly below the forecast. Excluding the provisions for litigation in the USA, which were reported in an ad hoc announcement dated July 21, 2024, the EBITDA of kEUR +357 would even be at the upper end of the original forecast for the 2024 financial year.

For 2025, the Company expects positive EBITDA of between kEUR 0,000 and kEUR 3,000, revenues of kEUR 20,000 to kEUR 24,000 and average revenue growth of 10% to 12% p.a. in Europe, while revenues from the US licensing business are expected to remain at the previous year's level (kEUR 9,415) due to the low transfer price for 2025. An increase is not expected until 2026.

Provided that expenses and revenues develop as planned, the Biofrontera Group expects to be able to meet all obligations in the 2025 financial year and to have liquidity of kEUR 500 to kEUR 1,500 as of December 31, 2025, based on current corporate planning.

(End)

Sender: Biofrontera AG address: Hemmelrather Weg 201, 51377 Leverkusen Country: Germany Contact: Investor Relations Phone: +49 (0) 214 87 63 20E-mail: ir@biofrontera.comWebsite: www.biofrontera.com

ISIN(s): DE000A4BGGM7 (share)Listed: Regulated Market in Düsseldorf, Frankfurt; Regulated Unofficial Market in Munich, Regulated Unofficial Market in Stuttgart; Regulated Unofficial Market in Berlin, Tradegate"

(end)

---

Emitter:	Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany
Contact Person:	Investor Relations
Phone:	+49 (0) 214 87 63 20
E-Mail:	ir@biofrontera.com
Website:	www.biofrontera.com
ISIN(s):	DE000A4BGGM7 (Share)
Stock Exchange(s):	Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate

[ source: https://www.pressetext.com/news/1744659300336 ]

(c) pressetext Nachrichtenagentur GmbH Ad-hoc and financial news distributed by pressetext. Archive: https://www.pressetext.com/channel/Adhoc The emitter is responsible for the content. Contact: adhoc@pressetext.com or +43-1-81140-0.